Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops

Daull P., Barabino S., Feraille L., Kessal K., Docquier M., Parsadaniantz S.M., Baudouin C., Garrigue J.-S.

2019
Current Eye Research

View publication

Therapeutic Area

Front of the eye (FOTE)
Technology

Other
Categories

Preclinical development

Affiliations

Novagali Innovation Center, SANTEN SAS, Novagali Innovation Center, Evry Cedex, France; Ocular Surface & Dry Eye Center, Ospedale L. Sacco, University of Milan, Milan, Italy; Iris Pharma, Les Nertières, Allée Hector Pintus, La Gaude, France; Vision Institute UMR S 968, UMR 7210 CNRS, Paris Sorbonne Universités, Paris, France; iGE3, University of Geneva Medical School, Geneva 4, Switzerland; CHNO XV-XX Hospital, Paris, France

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.

Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022